Filter Results:
(6,050)
Show Results For
- All HBS Web
(6,050)
- People (18)
- News (1,017)
- Research (4,074)
- Events (16)
- Multimedia (34)
- Faculty Publications (3,170)
Show Results For
- All HBS Web
(6,050)
- People (18)
- News (1,017)
- Research (4,074)
- Events (16)
- Multimedia (34)
- Faculty Publications (3,170)
Page 1 of 6,050
Results →
- February 2024 (Revised April 2024)
- Case
Finberg: Corporate Venture Capital in Türkiye
By: Paul A. Gompers and Namrata Arora
In December 2021, Murat Özyeğin, Chairman of Fiba Holding, along with Ömer Mert and İhsan Elgin, engaged in discussions about the future of United Payment, a fintech company in which Finberg, a subsidiary of Fibabanka, held a 20% stake. Finberg, established in 2018 as... View Details
Keywords: Corporate Venture Capital; Technology; Return On Investment; Venture Capital; Investment; Strategy; Technological Innovation; Competition; Valuation; Acquisition; Business Startups; Information Technology Industry; Banking Industry; Middle East; North Africa; Turkey; Ukraine; Romania; Poland
Gompers, Paul A., and Namrata Arora. "Finberg: Corporate Venture Capital in Türkiye." Harvard Business School Case 824-175, February 2024. (Revised April 2024.)
- February 2006 (Revised July 2007)
- Case
Corporate Venture Capital at Eli Lilly
By: Richard G. Hamermesh, Ron Laufer and David Lane
Reviews the role of corporate venture capital and its history at Eli Lilly. Also presents a challenging venture investment opportunity. View Details
Hamermesh, Richard G., Ron Laufer, and David Lane. "Corporate Venture Capital at Eli Lilly." Harvard Business School Case 806-092, February 2006. (Revised July 2007.)
- December 2018 (Revised March 2019)
- Case
R/GA: Corporate Venture Studio vs. Accelerator
By: Andy Wu, Grant Son and Aastha Thakkar
New approach to accelerating the development of innovation through corporate venturing by creating partnerships between startup venture and established corporations through the launch of the Global Sports Venture Studios created by R/GA Ventures and the Los Angeles... View Details
Keywords: Start-ups; Entrepreneurial Finance; Corporate Venture Capital; Incubators; Accelerators; Startup Financing; Innovation; Partnerships; Ecosystems; Entrepreneurship; Business Startups; Finance; Venture Capital; Partners and Partnerships; Innovation and Invention; Sports Industry; Technology Industry; Entertainment and Recreation Industry; United States; New York (city, NY); Los Angeles
Wu, Andy, Grant Son, and Aastha Thakkar. "R/GA: Corporate Venture Studio vs. Accelerator." Harvard Business School Case 719-414, December 2018. (Revised March 2019.)
- January 2016 (Revised October 2016)
- Case
Saudi Aramco and Corporate Venture Capital
By: Joseph B. Fuller, Matthew Rhodes-Kropf and Nathaniel Burbank
Saudi Aramco launched an internal venture capital arm in 2011, which promptly became the world's largest investor in energy related startups. In choosing to proceed, the company's New Business Development unit (NPD) wrestled with a number of challenges. How should the... View Details
Fuller, Joseph B., Matthew Rhodes-Kropf, and Nathaniel Burbank. "Saudi Aramco and Corporate Venture Capital." Harvard Business School Case 816-068, January 2016. (Revised October 2016.)
- 2023
- Working Paper
Fencing Off Silicon Valley: Cross-Border Venture Capital and Technology Spillovers
By: Ufuk Akcigit, Sina T. Ates, Josh Lerner, Richard Townsend and Yulia Zhestkova
The treatment of foreign investors is a contentious topic in U.S. entrepreneurship policy. We
model a setting where foreign corporate investments in Silicon Valley may allow U.S. entrepreneurs
to pursue technologies that they could not otherwise, but may also lead to... View Details
Keywords: Innovation; Corporate Venture Capital; Knowledge Spillovers; Innovation and Invention; Foreign Direct Investment; Venture Capital; Entrepreneurship; Policy; United States
Akcigit, Ufuk, Sina T. Ates, Josh Lerner, Richard Townsend, and Yulia Zhestkova. "Fencing Off Silicon Valley: Cross-Border Venture Capital and Technology Spillovers." Harvard Business School Working Paper, No. 21-043, September 2020. (Revised September 2023. Conditionally Accepted, Journal of Monetary Economics.)
- January 2014
- Teaching Plan
MedImmune Ventures
By: Richard Hamermesh and Andrew Otazo
"MedImmune Ventures" highlights the problems faced by corporate venture capital firms, the challenges of investing in early-stage healthcare, and the difficulty of operating in distant markets. View Details
Keywords: MedImmune Ventures; NeuProtect; Corporate Venture Capital; Ron Laufer; Australia; Starfish Ventures; AstraZeneca; MEVE; Healthcare; Startup; Venture Capital; Business Startups; Health Industry; Australia; United States
Hamermesh, Richard, and Andrew Otazo. "MedImmune Ventures." Harvard Business School Teaching Plan 814-039, January 2014.
- 06 Nov 2000
- Research & Ideas
The Determinants of Corporate Venture Capital Success
Corporate-sponsored venture funds first appeared in the 1960s, about two decades after the first flowering of the venture capital industry. Ever since, they have mirrored the... View Details
Keywords: by Paul Gompers & Josh Lerner
- September 2024
- Case
TechEnergy Ventures: Innovating Through Corporate Venture Capital
By: Rebecca Karp and Lena Duchene
This case examines TechEnergy Ventures, the corporate venture capital (CVC) arm of the Techint Group, and its role in scaling innovation within the energy sector. Founded in 2021, TechEnergy Ventures operates with a mandate to invest in disruptive technologies to... View Details
Keywords: Transition; Alternative Energy; Renewable Energy; Metals and Minerals; Mining; Corporate Entrepreneurship; Climate Change; Environmental Sustainability; Corporate Finance; Venture Capital; Financial Strategy; Investment Portfolio; Growth and Development Strategy; Adaptation; Diversification; Innovation Strategy; Energy Industry; Financial Services Industry; Italy; Europe; Latin America; Argentina
Karp, Rebecca, and Lena Duchene. "TechEnergy Ventures: Innovating Through Corporate Venture Capital." Harvard Business School Case 725-393, September 2024.
- August 2013 (Revised October 2013)
- Case
MedImmune Ventures
By: Richard G. Hamermesh and David Lane
Ron Laufer is the new Senior Managing Director of MedImmune Ventures, the corporate venture capital arm of AstraZeneca, a leading pharmaceuticals firm. Laufer has to decide whether to pursue a high-potential, but very risky, early-stage investment. The decision Laufer... View Details
Keywords: MedImmune; MedImmune Ventures; AstraZeneca; NeuProtect; Corporate Venturing; Biotechnology; Venture Investing; Venture Capital; Health Care and Treatment; Pharmaceutical Industry; Financial Services Industry; Biotechnology Industry; United States; Australia; Europe; London
Hamermesh, Richard G., and David Lane. "MedImmune Ventures." Harvard Business School Case 814-023, August 2013. (Revised October 2013.)
- Teaching Interest
Economics of Entrepreneurship and Venture Capital
Designed for Harvard College sophomores.
Course Description: Why do so many individuals choose to pursue entrepreneurship despite substantial risks? How do these entrepreneurs raise money to finance their ventures? And what is the impact of... View Details
- 22 May 2014
- News
To Crack the Glass Ceiling, Start with Venture Capital
- November 2006 (Revised May 2007)
- Supplement
Corporate Venture Capital at Eli Lilly
Hamermesh, Richard G. "Corporate Venture Capital at Eli Lilly." Harvard Business School Video Supplement 807-705, November 2006. (Revised May 2007.)
- October 2016
- Teaching Note
Saudi Aramco and Corporate Venture Capital
By: Joseph B. Fuller and Sarah McAra
- October 2013
- Article
Corporate Venturing
By: Josh Lerner
For decades, large companies have been wary of corporate venturing. But as R&D organizations face pressure to rein in costs and produce results, companies are investing in promising start-ups to gain knowledge and agility. The logic of corporate venturing is... View Details
Keywords: Venture Capital; Knowledge Acquisition; Corporate Strategy; Research and Development; Business Startups; Innovation and Invention
Lerner, Josh. "Corporate Venturing." Harvard Business Review 91, no. 10 (October 2013): 86–94.
- 29 Apr 2008
- Research Event
Venture Capital
Date: January 9-10, 2008 Faculty Chairs: Josh Lerner, William Sahlman Faculty Summary Report: Colloquium: Venture Capital What were the overall goals of the colloquium? The VC Conference is one in a series... View Details
Venture Capital Journey
Venture Capital Journey (VCJ) is an MBA elective field course for students who plan to embark on a career in venture capital. The focus of the course is to provide students with frameworks, tools, a network, and hands on experience in preparation... View Details
- March 2017 (Revised January 2019)
- Case
Aspect Ventures
By: Paul Gompers, Danielle Li and Silpa Kovvali
Gompers, Paul, Danielle Li, and Silpa Kovvali. "Aspect Ventures." Harvard Business School Case 217-046, March 2017. (Revised January 2019.)
- September 2006
- Teaching Note
Corporate Venture Capital at Eli Lilly (TN)
By: Richard G. Hamermesh and Erin Seefeld
- Fast Answer
Corporate venture capital subsidiaries: how to identify
How can I find which firms have corporate venture capital subsidiaries? Capital IQ allows you to create a list of View Details
- February 2024 (Revised July 2024)
- Case
Korea Venture Investment Corporation
By: Paul A. Gompers and Billy Chan
Financial service sector Korea Venture Investment Corporation (KVIC) is the venture capital arm of the Korean government with a founding mission to build a domestic startup ecosystem that would be as competitive as Silicon Valley. KVIC manages a basket of... View Details
Keywords: Entrepreneurship; Society; Investment; Venture Capital; Mission and Purpose; State Ownership; Financial Services Industry; Asia; South Korea
Gompers, Paul A., and Billy Chan. "Korea Venture Investment Corporation." Harvard Business School Case 224-022, February 2024. (Revised July 2024.)